JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB10485

Anti-KAT3B / p300 antibody

5

(3 Reviews)

|

(41 Publications)

Anti-KAT3B / p300 antibody (ab10485) is a rabbit polyclonal antibody detecting KAT3B / p300 in Western Blot, IP. Suitable for Human.

- Over 30 publications
- Trusted since 2004

View Alternative Names

P300, EP300, Histone acetyltransferase p300, p300 HAT, E1A-associated protein p300, Histone butyryltransferase p300, Histone crotonyltransferase p300, Protein 2-hydroxyisobutyryltransferase p300, Protein isonicotinyltransferase p300, Protein lactyltransferas p300, Protein propionyltransferase p300

5 Images
Western blot - Anti-KAT3B / p300 antibody (AB10485)
  • WB

Lab

Western blot - Anti-KAT3B / p300 antibody (AB10485)

Western blot : Anti-EP300 antibody (ab10485) staining at 1/15000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab10485 was shown to bind specifically to EP300. A band was observed at 200/90-130 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in EP300 knockout cell line. To generate this image, wild-type and EP300 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-KAT3B / p300 antibody (ab10485) at 1/15000 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

EP300 knockout HCT 116 cell lysate at 20 µg

Lane 2:

Western blot - Human EP300 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-ep300-knockout-hct116-cell-line-ab286395'>ab286395</a>)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

Human brain olfactory lobe cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 200 kDa,90-130 kDa

false

Immunoprecipitation - Anti-KAT3B / p300 antibody (AB10485)
  • IP

Supplier Data

Immunoprecipitation - Anti-KAT3B / p300 antibody (AB10485)

KAT3B/p300 was immunoprecipitated from 1 mg HEK293T whole cell lysate with ab10485 at 6 μg per reaction. Western blot was performed on the immunoprecipitate using ab10485 at 0.04 μg/mL.

Lysates prepared using NETN lysis buffer.

Lane 1 : ab10485 IP in HEK293T whole cell lysate.

Lane 2 : Contol IgG in HEK293T whole cell lysate.

Detection : Chemiluminescence.

Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-KAT3B / p300 antibody (ab10485)

Predicted band size: 264 kDa

false

Western blot - Anti-KAT3B / p300 antibody (AB10485)
  • WB

Supplier Data

Western blot - Anti-KAT3B / p300 antibody (AB10485)

Detection : Chemiluminescence.

Lysates prepared using NETN lysis buffer.

All lanes:

Western blot - Anti-KAT3B / p300 antibody (ab10485) at 0.04 µg/mL

Lane 1:

HEK293T whole cell lysate at 15 µg

Lane 2:

Jurkat whole cell lysate at 15 µg

Lane 3:

HeLa whole cell lysate at 15 µg

Predicted band size: 264 kDa

false

Exposure time: 10s

Western blot - Anti-KAT3B / p300 antibody (AB10485)
  • WB

AbReview45923****

Western blot - Anti-KAT3B / p300 antibody (AB10485)

Blocking Solution and Diluent 5% milk in TBS

All lanes:

Western blot - Anti-KAT3B / p300 antibody (ab10485) at 1/5000 dilution

Lane 1:

Human MCF-7 Cell Lysate at 50000 Cells

Lane 2:

MDA-MB-231 Cell Lysate at 50000 Cells

Secondary

All lanes:

Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (<a href='/en-us/products/secondary-antibodies/vhh-single-domain-rabbit-igg-fc-hrp-ab191866'>ab191866</a>)

Predicted band size: 264 kDa

true

Exposure time: 3min

This image is courtesy of an anonymous Abreview

Western blot - Anti-KAT3B / p300 antibody (AB10485)
  • WB

AbReview61445****

Western blot - Anti-KAT3B / p300 antibody (AB10485)

All lanes:

Western blot - Anti-KAT3B / p300 antibody (ab10485) at 1/4000 dilution

Lane 2:

PC3 cell lysate. (parent cell line) at 38 µg

Lane 3:

PC3 with dox. inducible p300 shRNA, untreated at 38 µg

Lane 4:

PC3 with dox. inducible p300 shRNA, doxcycline treated with 60 ng/ml doxycycline for 72 hours for shRNA induction at 38 µg

Secondary

All lanes:

IRDye 680RD Goat anti-Rabbit IgG (H + L) at 1/15000 dilution

Predicted band size: 264 kDa

false

This image is courtesy of an abreview by Florian Handle

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB

applications

Immunogen

Synthetic Peptide within Human EP300 aa 950-1000. The exact immunogen used to generate this antibody is proprietary information.

Q09472

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1-4 µg/mg of lysate", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/25000", "WB-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-KAT3B / p300 antibody (ab10485) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human samples.

Trusted by the scientific community
Anti-KAT3B / p300 (ab10485) was first used in a scientific publication in 2004 and has been cited over 30 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab10485 was affinity purified using the peptide immobilized on solid support.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

KAT3B also known as p300 is a histone acetyltransferase with a molecular weight of approximately 300 kDa. Known for its ability to acetylate histone and non-histone proteins p300 modulates gene expression by altering chromatin structure. The protein is ubiquitously expressed across various tissues impacting numerous cellular processes by its mechanical functions of modifying chromatin.
Biological function summary

KAT3B/p300 influences multiple cellular activities like cell growth differentiation and apoptosis. It functions as a transcriptional coactivator and integrates various signaling pathways into the cell's gene expression program. p300 often forms complexes with other transcription factors enhancing or repressing their activity based on the cellular context. By modifying transcription factors it plays an essential role in controlling cell fate decisions.

Pathways

P300 participates in the regulation of significant cellular processes including the Wnt signaling pathway and the p53 pathway. In the Wnt signaling pathway p300 acts alongside beta-catenin to regulate gene expression while in the p53 pathway it acetylates the p53 protein influencing the cell’s response to DNA damage. These pathways highlight p300's interaction with important proteins such as CBP (CREB-binding protein) which shares a similar functional repertoire and works synergistically in gene regulation.

P300 is implicated in cancers and congenital disorders. In cancer aberrant regulation or mutation of p300 can lead to uncontrolled cell proliferation and tumor growth; p300 inhibitors like C646 are researched for their therapeutic potential. Additionally Rubinstein-Taybi syndrome a congenital disorder results from mutations in the p300 gene showcasing p300’s importance in developmental processes. The interplay of p300 with proteins such as CBP is also relevant in these conditions where disrupted interactions may lead to disease manifestation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed : 23415232, PubMed : 23934153, PubMed : 40240600, PubMed : 8945521). Acetylates all four core histones in nucleosomes (PubMed : 23415232, PubMed : 23934153, PubMed : 8945521). Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed : 23415232, PubMed : 23934153, PubMed : 8945521). Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability (PubMed : 23415232). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed : 21131905, PubMed : 23911289). Also able to acetylate histone lysine residues that are already monomethylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed : 37731000). Catalyzes formation of histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed : 37731000). In response to DNA damage, catalyzes acetylation of histone H1 at 'Lys-75' (H1K75ac) following histone H1 deamidation by CTPS1, increasing chromatin accessibility to facilitate the recruitment of DNA repair proteins (PubMed : 40240600). Also functions as acetyltransferase for non-histone targets, such as ALX1, HDAC1, PRDM16, PRMT1, SIRT2, STAT3, ZNF76 or GLUL (PubMed : 12929931, PubMed : 15653507, PubMed : 16285960, PubMed : 16337145, PubMed : 16762839, PubMed : 18722353, PubMed : 18782771, PubMed : 26990986). Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed : 12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of p53/TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed : 18722353). Following DNA damage, forms a stress-responsive p53/TP53 coactivator complex with JMY which mediates p53/TP53 acetylation, thereby increasing p53/TP53-dependent transcription and apoptosis (PubMed : 11511361, PubMed : 15448695). Promotes chromatin acetylation in heat shock responsive HSP genes during the heat shock response (HSR), thereby stimulating HSR transcription (PubMed : 18451878). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed : 16762839). Acetylates 'Lys-247' of EGR2 (By similarity). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed : 12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement (PubMed : 14752053). Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed : 15890677). Acetylates STAT3 at different sites, promoting both STAT3 dimerization and activation and recruitment to chromatin (PubMed : 15653507, PubMed : 16285960, PubMed : 18782771). Acetylates BCL6 which disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed : 12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed : 14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed : 16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed : 20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed : 24939902). Acetylates MEF2D (PubMed : 21030595). Acetylates and stabilizes ZBTB7B protein by antagonizing ubiquitin conjugation and degradation, this mechanism may be involved in CD4/CD8 lineage differentiation (PubMed : 20810990). Acetylates GABPB1, impairing GABPB1 heterotetramerization and activity (By similarity). Acetylates PCK1 and promotes PCK1 anaplerotic activity (PubMed : 30193097). Acetylates RXRA and RXRG (PubMed : 17761950). Acetylates isoform M2 of PKM (PKM2), promoting its homodimerization and conversion into a protein kinase (PubMed : 24120661). Acetylates RPTOR in response to leucine, leading to activation of the mTORC1 complex (PubMed : 30197302, PubMed : 32561715). Acetylates RICTOR, leading to activation of the mTORC2 complex (PubMed : 22084251). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREBBP (PubMed : 8917528). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), lactoyl-CoA, propanoyl-CoA (propionyl-CoA) or isonicotinyl-CoA, and is able to mediate protein crotonylation, butyrylation, 2-hydroxyisobutyrylation, lactylation, propionylation or isonicotinylation, respectively (PubMed : 17267393, PubMed : 25818647, PubMed : 29775581, PubMed : 31645732, PubMed : 34545082). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed : 25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low (PubMed : 25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed : 17267393). Catalyzes histone lactylation in macrophages by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription (PubMed : 31645732). Acts as a protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by mediating 2-hydroxyisobutyrylation of glycolytic enzymes (PubMed : 29775581). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed : 25514493).. (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein.
See full target information EP300

Publications (41)

Recent publications for all applications. Explore the full list and refine your search

Nucleic acids research 53: PubMed40705926

2025

PPARG-centric transcriptional re-wiring during differentiation of human trophoblast stem cells into extravillous trophoblasts.

Applications

Unspecified application

Species

Unspecified reactive species

Qingqing Guo,Joonhyuk Choi,Muyoung Lee,Jonghwan Kim

PloS one 20:e0322962 PubMed40392781

2025

ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation.

Applications

Unspecified application

Species

Unspecified reactive species

Jeong Eun Kang,Hyun Wook Seo,Dong-Eun Kim,Young Hyun Shin,Songmee Bae,Cheol-Hee Yoon

Nature communications 15:3483 PubMed38664416

2024

Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Noha A M Shendy,Melissa Bikowitz,Logan H Sigua,Yang Zhang,Audrey Mercier,Yousef Khashana,Stephanie Nance,Qi Liu,Ian M Delahunty,Sarah Robinson,Vanshita Goel,Matthew G Rees,Melissa A Ronan,Tingjian Wang,Mustafa Kocak,Jennifer A Roth,Yingzhe Wang,Burgess B Freeman,Brent A Orr,Brian J Abraham,Martine F Roussel,Ernst Schonbrunn,Jun Qi,Adam D Durbin

Nature communications 15:1285 PubMed38346993

2024

The transcriptional regulatory network modulating human trophoblast stem cells to extravillous trophoblast differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Mijeong Kim,Yu Jin Jang,Muyoung Lee,Qingqing Guo,Albert J Son,Nikita A Kakkad,Abigail B Roland,Bum-Kyu Lee,Jonghwan Kim

Discover. Oncology 14:28 PubMed36853387

2023

Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Wang,Zhiyong Zhou

Pharmaceuticals (Basel, Switzerland) 16: PubMed36678613

2023

Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels).

Applications

Unspecified application

Species

Unspecified reactive species

Izabela Szymczak-Pajor,Józef Drzewoski,Ewa Świderska,Justyna Strycharz,Anna Gabryanczyk,Jacek Kasznicki,Marta Bogdańska,Agnieszka Śliwińska

Cell death & disease 13:463 PubMed35568711

2022

m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jian-Xian Lin,Ning-Zi Lian,You-Xin Gao,Qiao-Ling Zheng,Ying-Hong Yang,Yu-Bin Ma,Zhi-Song Xiu,Qing-Zhu Qiu,Hua-Gen Wang,Chao-Hui Zheng,Ping Li,Jian-Wei Xie,Jun Lu,Qi-Yue Chen,Long-Long Cao,Mi Lin,Jia-Bin Wang,Chang-Ming Huang

Nature communications 13:1855 PubMed35388006

2022

Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery.

Applications

Unspecified application

Species

Unspecified reactive species

Tian Zhou,Xinyi Zhu,Zhizhong Ye,Yong-Fei Wang,Chao Yao,Ning Xu,Mi Zhou,Jianyang Ma,Yuting Qin,Yiwei Shen,Yuanjia Tang,Zhihua Yin,Hong Xu,Yutong Zhang,Xiaoli Zang,Huihua Ding,Wanling Yang,Ya Guo,John B Harley,Bahram Namjou,Kenneth M Kaufman,Leah C Kottyan,Matthew T Weirauch,Guojun Hou,Nan Shen

Biomaterials 279:121236 PubMed34753038

2021

A Src-H3 acetylation signaling axis integrates macrophage mechanosensation with inflammatory response.

Applications

Unspecified application

Species

Unspecified reactive species

Praveen Krishna Veerasubramanian,Hanjuan Shao,Vijaykumar S Meli,Tri Andrew Q Phan,Thuy U Luu,Wendy F Liu,Timothy L Downing

Molecular medicine reports 24: PubMed34468010

2021

Knockdown of MIR9‑3HG inhibits proliferation and promotes apoptosis of cervical cancer cells by miR‑498 via EP300.

Applications

Unspecified application

Species

Unspecified reactive species

Fang Li,Ying Liang,Pian Ying
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com